KLBF:IDX
卡尔贝制药公司
IDR 790.00
arrow_upward
+1.28%(+10.00) 1 天
10月15日, GMT+7 16:13:44 · IDR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 KLBF 生成关键数据洞见…
开盘价
IDR 780
最高价
IDR 795
最低价
IDR 775
市值
36.98万亿
平均成交量
6364.30万
成交量
4192.47万
股息
2.53%
季度股息
IDR 5
除息日
2026年6月4日
市盈率
9.93
52 周最高价
IDR 1,345
52 周最低价
IDR 630
每股收益
IDR 80
流通股数
468.13亿
员工人数
1万
开盘价
IDR 780
最高价
IDR 795
最低价
IDR 775
市值
36.98万亿
平均成交量
6364.30万
成交量
4192.47万
股息
2.53%
季度股息
IDR 5
除息日
2026年6月4日
市盈率
9.93
52 周最高价
IDR 1,345
52 周最低价
IDR 630
每股收益
IDR 80
流通股数
468.13亿
员工人数
1万
新闻报道
来自网络来源和新闻合作伙伴
资料
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
卡尔贝制药公司简介